Share Your Story With Us Today And Earn Up To $100 Off Your Next Order Submit A Testimonial Video
This is the proven science behind GLP-1 medications, also known as GLP-1 receptor agonists medicines built around glucagon-like peptide-1, a natural gut hormone, now more accessible in India in 2026
Rotate sites
Emerging evidence suggests that GLP1 therapy can: Reduce hepatic fat content, as shown in MRI-PDFF studies Lower markers of liver inflammation and fibrosis Improve insulin sensitivity and metabolic control Although most trials focus on obese or diabetic populations, livercentric endpoints are increasingly evaluated, and benefits appear to extend beyond weight loss alone
By week 24, total weight loss from baseline commonly falls in the 12-18% range, though individual results vary significantly based on starting weight, diet, exercise, and metabolic factors
The FDA Has Not Issued Guidance Supporting the State Boards Interpretation Compounded medications are not FDA-approved